Skip to main content

Top trends in the biotech market

After a COVID-era high and then post-pandemic crash, the biotech market has returned to a new normal in recent years. But fresh challenges to the flow of startup investments have been lurking around many corners. Specific therapeutic areas such as oncology remain hot investment targets, and fast-growing sectors like weight loss are swinging up.

included in this trendline
  • Lilly’s former small molecule head makes the leap to a rising biotech in obesity
  • Biotechs emerging from stealth take aim at pharma’s prime targets
  • After an up and down year, pharma’s R&D landscape is shifting again
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.